NantBio, Inc. — Form D
NantBio, Inc. of El Segundo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-13. The offering totals $75.1M, of which $75.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-13
- Form: D
- Accession: 0001608318-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $75.1M
- Amount sold: $75.1M
- Investors: 6
- Date of first sale: 2023-11-08
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-496950
Issuer
- Name: NantBio, Inc.
- CIK: 0001608318
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 450 Duley Road, El Segundo, CA, 90245
- Phone: 310-853-7888
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Charles Kenworthy | Director | El Segundo, CA |
| Douglas Reed Maughan | Director | Schaumburg, IL |
| Patrick Soon-Shiong | Director | Colorado Springs, CO |
| James Banaag | Executive Officer | El Segundo, CA |
| Charles Kenworthy | Executive Officer | El Segundo, CA |
| Patrick Soon-Shiong | Executive Officer | Colorado Springs, CO |
| Patrick Shoon-Shiong | Director | Culver City, CA |
Other filings by this issuer (5)
More